115 related articles for article (PubMed ID: 15580650)
1. Endothelin-mediated remodeling in aortas of diabetic rats.
Fukuda G; Khan ZA; Barbin YP; Farhangkhoee H; Tilton RG; Chakrabarti S
Diabetes Metab Res Rev; 2005; 21(4):367-75. PubMed ID: 15580650
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
3. C-peptide and retinal microangiopathy in diabetes.
Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
[TBL] [Abstract][Full Text] [Related]
4. Endothelins: regulators of extracellular matrix protein production in diabetes.
Khan ZA; Farhangkhoee H; Mahon JL; Bere L; Gonder JR; Chan BM; Uniyal S; Chakrabarti S
Exp Biol Med (Maywood); 2006 Jun; 231(6):1022-9. PubMed ID: 16741042
[TBL] [Abstract][Full Text] [Related]
5. Leptin and endothelin-1 mediated increased extracellular matrix protein production and cardiomyocyte hypertrophy in diabetic heart disease.
Majumdar P; Chen S; George B; Sen S; Karmazyn M; Chakrabarti S
Diabetes Metab Res Rev; 2009 Jul; 25(5):452-63. PubMed ID: 19391127
[TBL] [Abstract][Full Text] [Related]
6. EDB fibronectin and angiogenesis -- a novel mechanistic pathway.
Khan ZA; Chan BM; Uniyal S; Barbin YP; Farhangkhoee H; Chen S; Chakrabarti S
Angiogenesis; 2005; 8(3):183-96. PubMed ID: 16308732
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
Yuan J; Jia R; Bao Y
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications.
Chen S; Khan ZA; Cukiernik M; Chakrabarti S
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1089-97. PubMed ID: 12582013
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.
Chen S; Evans T; Mukherjee K; Karmazyn M; Chakrabarti S
J Mol Cell Cardiol; 2000 Sep; 32(9):1621-9. PubMed ID: 10966825
[TBL] [Abstract][Full Text] [Related]
10. Renal, retinal and cardiac changes in type 2 diabetes are attenuated by macitentan, a dual endothelin receptor antagonist.
Sen S; Chen S; Feng B; Iglarz M; Chakrabarti S
Life Sci; 2012 Oct; 91(13-14):658-68. PubMed ID: 22525377
[TBL] [Abstract][Full Text] [Related]
11. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells].
Li XD; Chen XW; Tang DS; Liang D; Liu HF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):140-2. PubMed ID: 17286908
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.
Chen S; Feng B; George B; Chakrabarti R; Chen M; Chakrabarti S
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E127-37. PubMed ID: 19903865
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Shimojo N; Masuzawa K; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
15. Glucose-induced serum- and glucocorticoid-regulated kinase activation in oncofetal fibronectin expression.
Khan ZA; Barbin YP; Farhangkhoee H; Beier N; Scholz W; Chakrabarti S
Biochem Biophys Res Commun; 2005 Apr; 329(1):275-80. PubMed ID: 15721303
[TBL] [Abstract][Full Text] [Related]
16. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 regulates cell growth and causes downregulation of SMemb/non-muscle myosin heavy chain B mRNA in human prostate stromal cells.
Obara K; Bilim V; Suzuki K; Kobayashi K; Hara N; Kasahara T; Nishiyama T; Takahashi K
Scand J Urol Nephrol; 2005; 39(5):366-71. PubMed ID: 16257837
[TBL] [Abstract][Full Text] [Related]
18. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
19. A DNA enzyme against plasminogen activator inhibitor- type 1 (PAI-1) limits neointima formation after angioplasty in an obese diabetic rodent model.
Witkowski P; Seki T; Xiang G; Martens T; Sondermeijer H; See F; Bhagat G; Schuster M; Hardy MA; Itescu S
J Cardiovasc Pharmacol; 2007 Dec; 50(6):633-40. PubMed ID: 18091579
[TBL] [Abstract][Full Text] [Related]
20. Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats.
Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):1034-9. PubMed ID: 16741044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
